Phase II study of neoadjuvant chemotherapy with L-OHP and S-1 for locally advanced rectal cancer (NCCSG-09) - Phase II study of neoadjuvant chemotherapy locally advanced rectal cancer (NCCSG-09)

iigata Colorectal cancer Chemotherapy Study Group (NCCSG)0 个研究点目标入组 35 人开始时间: 2013年1月15日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) with sensory neuropathy 2) with active double cancer 3) had active infection disease (over 38.0 degree) 4) with sever diarrhea 5) had serious complication (e.g. interstitialpneumonia, or pulmonary fibrosis, kidney injury, hepatic failure, uncontrolled diabetes mellitus, uncontrolled hypertension) 6) with previous serious drug hyperseneitivity 7) with significant abnormal electrocardiogram or cardiovascular disease (e.g. heart failure, myocardial infarction, angina pectoris) 8) with myelosupression 9) with chickenpox 10) had pleural effusion or ascites which need therapy 11) receiving Flucytosine 12) Pregnant or lactating women, women who are capable of pregnancy, intend to get pregnant or men who want to get their partners pregnant 13) had a previous serious drug allergies 14) were systemically-administered of steroids 15) with jaundice 16) except referred to above, physician in charge of this trial gave a diagnosis the patient who can not joint this trail for the safety.

发起方

iigata Colorectal cancer Chemotherapy Study Group (NCCSG)